Skip to content

Phibro Animal Health

US · PAHC #2966 by market cap Listed 1970
33.29 -0.79 -2.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 14 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.3 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
54.68% +1.28pp
Institutions
287 +14
As of
2026/Q3 vs. prior period

Holder types

Individual/Insider48.47%
Mutual Fund44.13%
Hedge Fund5.87%
Public Company2.11%
Insurance Company0.78%
Government Pension Fund0.74%
Private Company0.68%
Family Office/Trust0.32%

Top holders as of 2026-09-07

Jack Bendheim 48.16% · 19.56M sh
FMR 8.04% · 3.27M sh
BlackRock 8.00% · 3.25M sh
Millennium Management LLC 2.62% · 1.06M sh
State Street Global Advisors 2.57% · 1.04M sh
Vanguard Capital Management, LLC 2.27% · 919.85K sh
Lord, Abbett & Co. LLC 1.61% · 653.31K sh
Geode Capital Management, LLC 1.50% · 610.08K sh
Dimensional Fund Advisors 1.33% · 538.51K sh
Vanguard Portfolio Management, LLC 1.16% · 472.97K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 17 buys · 33 sells

NameRoleStake
Jack Bendheim Executive Chairperson 48.16%
Glenn David Chief Financial Officer 0.12%
E. Corcoran Independent Non-Executive Director 0.10%
Larry Miller Chief Operating Officer 0.08%
Jonathan Bendheim Executive VP of Talent, Technology and Business Development & Director 0.00%
Carol Wrenn Independent Director 0.00%
Daniel Bendheim Chief Executive Officer 0.00%
Judith Weinstein Senior Vice President 0.00%
Lisa Escudero Officer 0.00%
Anthony Andolino Former VP of Finance & Treasurer --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-15 Jack Bendheim Executive Chairperson Intent to Sell (Form 144) -350,000 $35.30
2026-08-05 Jack Bendheim Executive Chairperson Other Acquisition +12,103 --
2026-08-05 Daniel Bendheim Chief Executive Officer Other Acquisition +11,699 --
2026-08-05 Larry Miller Chief Operating Officer Other Acquisition +3,726 --
2026-08-05 Jonathan Bendheim Executive VP of Talent, Technology and Business Development & Director Other Acquisition +2,716 --
2026-08-05 Glenn David Chief Financial Officer Other Acquisition +3,482 --
2026-08-05 Lisa Escudero Officer Other Acquisition +1,547 --
2026-08-05 Judith Weinstein Senior Vice President Other Acquisition +2,478 --
2026-08-05 Patrick Rodriguez -- Other Acquisition +1,503 --
2026-08-03 Jack Bendheim Executive Chairperson Other Disposition -2,303 $36.60
2026-08-03 Daniel Bendheim Chief Executive Officer Other Disposition -486 $36.60
2026-08-03 Larry Miller Chief Operating Officer Other Disposition -635 $36.60
2026-08-03 Glenn David Chief Financial Officer Other Disposition -840 $36.60
2026-08-03 Lisa Escudero Officer Other Disposition -265 $36.60
2026-08-03 Judith Weinstein Senior Vice President Other Disposition -472 $36.60
2026-06-30 Daniel Bendheim Chief Executive Officer Other Derivative Acquisition +300,000 --
2026-06-15 Jack Bendheim Executive Chairperson Intent to Sell (Form 144) -281,600 $31.87
2026-05-28 E. Corcoran Independent Non-Executive Director Open Market Acquisition +10,000 $31.77
2026-05-06 Jack Bendheim Executive Chairperson Automatic Disposition -18,608 $47.59–58.13
2026-04-29 Jack Bendheim Executive Chairperson Automatic Disposition -21,120 $52.65–56.69

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Phibro Animal Health discussion 0 comments

Add a comment